Chart, Financials, Historical Prices, Industry, Insider, Messages, News, Profile, Reports, Research, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 23-May-2013
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 11)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
23-May-13ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for APPA11$126.50  View Abstract
23-May-13ValuEngine, Inc.N/AValuEngine Industry Report for Medical-drugs18$207  View Abstract
21-May-13GlobalDataGlobalDataA.P. Pharma, Inc. (APPA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile29$250  View Abstract
17-May-13Reuters Investment ProfileN/AA.P. Pharma Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138  View Abstract
17-May-13Ford Investor Services, Inc.N/AIndustry Value Graph: APPA , CPRX , NLTX , NBY , PATH , VTUS , ZGNX -- DRUGS3$34.50  View Abstract
17-May-13Ford Investor Services, Inc.N/AValue Graph: AP PHARMA -- APPA1$11.50  View Abstract
12-May-13Wright ReportsN/AWright Investors Service Comprehensive Report for AP Pharma, Inc.40$460  View Abstract
11-May-13S&P Capital IQ Quantitative ReportN/AAP Pharma6$69  View Abstract
10-May-13Plunkett Research, Ltd.Jack W PlunkettA.P. Pharma Inc. (APPA) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratios and Financial Averages49$99  View Abstract
5-Apr-13Pechala's ReportsFrantisek PechalaAP PHARMA INC (APPA) 12-months forecast1$15  View Abstract
Next 1

Independent Reports (Showing 1 to 10 of 11)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
23-May-13ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for APPA11$126.50View Abstract
23-May-13ValuEngine, Inc.N/AValuEngine Industry Report for Medical-drugs18$207View Abstract
21-May-13GlobalDataGlobalDataA.P. Pharma, Inc. (APPA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile29$250View Abstract
17-May-13Reuters Investment ProfileN/AA.P. Pharma Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138View Abstract
17-May-13Ford Investor Services, Inc.N/AIndustry Value Graph: APPA , CPRX , NLTX , NBY , PATH , VTUS , ZGNX -- DRUGS3$34.50View Abstract
17-May-13Ford Investor Services, Inc.N/AValue Graph: AP PHARMA -- APPA1$11.50View Abstract
12-May-13Wright ReportsN/AWright Investors Service Comprehensive Report for AP Pharma, Inc.40$460View Abstract
11-May-13S&P Capital IQ Quantitative ReportN/AAP Pharma6$69View Abstract
10-May-13Plunkett Research, Ltd.Jack W PlunkettA.P. Pharma Inc. (APPA) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratios and Financial Averages49$99View Abstract
5-Apr-13Pechala's ReportsFrantisek PechalaAP PHARMA INC (APPA) 12-months forecast1$15View Abstract
Next 1

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.